Treatment with lenalidomide in myelodysplastic syndromes with deletion 5q: results from the Dutch named patient program

Author(s):
Abouyahya, I.; Alhan, C.; Westers, T.M.; Boekhorst, P.A. te; Kappers-Klunne, M.C.; Coenen, J.L.; Heyning, F.H.; Huls, G.A.; Wolf, J.T. de; Imholz, A.L.; Koene, H.R.; Veth, G.; Kruijf, E.J.F.M. de; Muus, P.; Planken, E.V.; Segeren, C.M.; Vasmel, W.L.; Velden, A.M. van der; Velders, G.A.; Koedam, J.; Ossenkoppele, G.J.; Loosdrecht, A.A. van de
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-04-30
Language
English
Is part of
Leukemia & Lymphoma (2013), Vol. 54, no. 4, p. 874-877
hdl
1887/114370
doi
10.3109/10428194.2012.728702